Management

Ted Raad
Ted RaadTed Raad

Ted Raad
Chief Executive Officer & Director

Mr. Raad was appointed Chief Executive Officer in 2019. Prior to his appointment, he served as PULMATRiX’s Chief Business Officer and led commercial and business development efforts. He has 20 years of commercial healthcare and life science ...see more leadership experience and most recently served as Chief Commercial Officer at Option Care, where he helped separate the specialty home infusion business unit from Walgreens to create the nation’s largest independent home infusion provider. Prior to that, he was a business unit head at Sunovion with overall responsibility for CNS and respiratory products, including assets in asthma and COPD. During his time at Sunovion, Mr. Raad led multiple products through clinical development to commercialization and implemented new strategic alliances in the US and Japan. Earlier in his career, he also gained direct launch experience with Sporanox®, Janssen’s oral itraconazole product to treat fungal infections, and brings that experience to the PULMATRiX PUR1900 program. Mr. Raad holds a BS in Business Administration from University of Colorado at Boulder and an MBA from Thunderbird Global School of Global Management. ...see less

Margaret Wasilewski
Margaret WasilewskiMargaret Wasilewski

Margaret Wasilewski
Chief Medical Officer

Dr Wasilewski leverages over 25 years of experience in pharmaceutical drug development. She led the clinical development program for treatment and recurrence prevention in Clostridioides difficile infection as Vice President Research and Development-Medical at Summit Therapeutics. ...see more Dr. Wasilewski held various leadership roles at Eli Lilly and Company, Targanta Therapeutics, and Shire. Her clinical development experience includes bacterial and viral infections, sepsis, neurology, and rare disease. As President of ID Remedies, LLC, she has provided scientific, medical, and regulatory consultation and business development to various biopharmaceutical companies.

Dr. Wasilewski received a medical degree from Tufts University School of Medicine. She is board certified in Internal Medicine and completed fellowships in Infectious Diseases and Clinical Pharmacology at the University of California-San Francisco. Dr. Wasilewski received an MBA from Indiana University, Kelly School of Business; a master’s degree in Nutrition from the University of California-Berkeley and an undergraduate degree in Chemistry from Rutgers University. ...see less

Peter Ludlum
Peter LudlumPeter Ludlum

Peter Ludlum
Interim Chief Financial Officer

Mr. Ludlum is an experienced financial executive with over 23 years of work with early-stage and high growth companies within the life science sector. He is currently a Senior Director at Danforth Advisors, LLC, a financial consultancy that specializes in working with life sciences companies and Mr. Ludlum serves as the Strategic Advisor – Finance for Pulmatrix. ...see more

Previously, Mr. Ludlum has served in the roles of Co-President, Chief Business Officer, Chief Financial Officer, Financial Compliance Officer, and Group Controller at pharmaceutical, medical device and diagnostic products and reference laboratory companies.

Mr. Ludlum holds a B.S. in Business and Economics with a major in accounting from Lehigh University and a Masters in Business Administration with a concentration in Finance from California State University, Fullerton. ...see less

Jason Perry
Jason PerryJason Perry

JASON PERRY
Vice President CMC and Pharmaceutical Development

Mr. Perry is responsible for technical development of PULMATRiX’s product pipeline, including formulation development, process development, analytical development and manufacturing. ...see more Mr. Perry has 15 years of experience developing pharmaceutical products. Prior to joining Pulmatrix in 2012, he held formulation and process development roles at Alkermes, advancing oral, inhalation and parenteral dosage form products through early and late-phase development. He holds a BS in Chemical Engineering from the University of Massachusetts, Amherst. ...see less

Steven Kramer
Steven KramerSteven Kramer

STEVEN KRAMER
Vice President Quality

Mr. Kramer is responsible for the Quality function in addition to overseeing the safety and facilities functions at PULMATRIX. Since joining the company in 2009, Mr. Kramer has progressed through numerous roles of increasing responsibility. ...see more Prior to joining PULMATRIX, Mr. Kramer held position at Alkermes and AMAG Pharmaceutical and has over 15 years of experience in the pharmaceutical industry supporting the Quality Assurance and Quality Control functions. Mr. Kramer holds a Bachelor of Science degree in Forensic Toxicology from John Jay College of Criminal Justice and a Master of Science degree in Pharmaceutical Biotechnology from Northeastern University. ...see less

©2024 PULMATRiX, Inc.Produced in the USA.

Terms of UsePrivacy StatementContact Us